- Home
- RGR vs PCRX Comparison
RGR vs PCRX Comparison
Compare RGR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- PCRX
- Stock Information
- Founded
- RGR 1949
- PCRX 2006
- Country
- RGR United States
- PCRX United States
- Employees
- RGR N/A
- PCRX N/A
- Industry
- RGR Ordnance And Accessories
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- PCRX Health Care
- Exchange
- RGR Nasdaq
- PCRX Nasdaq
- Market Cap
- RGR 616.8M
- PCRX 1.2B
- IPO Year
- RGR N/A
- PCRX 2011
- Fundamental
- Price
- RGR $35.84
- PCRX $24.02
- Analyst Decision
- RGR
- PCRX Buy
- Analyst Count
- RGR 0
- PCRX 9
- Target Price
- RGR N/A
- PCRX $29.89
- AVG Volume (30 Days)
- RGR 202.5K
- PCRX 526.9K
- Earning Date
- RGR 07-30-2025
- PCRX 07-29-2025
- Dividend Yield
- RGR 1.95%
- PCRX N/A
- EPS Growth
- RGR N/A
- PCRX N/A
- EPS
- RGR 1.83
- PCRX N/A
- Revenue
- RGR $534,561,000.00
- PCRX $702,772,000.00
- Revenue This Year
- RGR N/A
- PCRX $7.54
- Revenue Next Year
- RGR $1.89
- PCRX $10.78
- P/E Ratio
- RGR $19.65
- PCRX N/A
- Revenue Growth
- RGR 0.65
- PCRX 3.08
- 52 Week Low
- RGR $32.74
- PCRX $11.16
- 52 Week High
- RGR $46.40
- PCRX $29.33
- Technical
- Relative Strength Index (RSI)
- RGR 44.41
- PCRX 36.83
- Support Level
- RGR $35.41
- PCRX $23.85
- Resistance Level
- RGR $36.40
- PCRX $25.16
- Average True Range (ATR)
- RGR 0.77
- PCRX 0.79
- MACD
- RGR -0.13
- PCRX -0.12
- Stochastic Oscillator
- RGR 20.85
- PCRX 8.20
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.